Grants and Contracts Details
Description
Abstract
The goal of this application is boost the intrinsic ability of macrophages to remove
dead/dying cells and growth-inhibitory molecules from the site of spinal cord injury (SCI)
without concurrently activating neurotoxic pro-inflammatory signaling pathways. By
doing so, less secondary tissue damage is expected at the injury site concomitant with
enhanced growth or plasticity of axons and improved functional recovery. We predict
that this can be accomplished through overexpression of the triggering receptor
expressed on myeloid cells (TREM)-2. We have developed a lentiviral vector system
for overexpressing TREM2 on cells. The goal of this propsal is to test the gene
specificity of the new construct, conduct optimization experiments with different
macrophage cell lines, and phenotype cells expressing the transgene. From these
experiments we hope to generate preliminary data for grants focused on modifying
macrophage phenotype in aged models of SCI.
Status | Finished |
---|---|
Effective start/end date | 10/1/12 → 12/31/12 |
Funding
- Craig H. Neilsen Foundation: $11,377.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.